Search Results - "Horii, Motoki"
-
1
Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells
Published in Scientific reports (22-01-2021)“…Psoriasis is an inflammatory cutaneous disease mediated by T-cell dependent immune responses; however, B cells are also considered to play an important role…”
Get full text
Journal Article -
2
Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
Published in Journal of dermatological science (01-03-2021)“…Janus kinase (JAK)-signal transducer and activator of transcription (STAT) was hyperactivated in biopsies from patients with systemic sclerosis (SSc) and in…”
Get full text
Journal Article -
3
-
4
The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis
Published in International journal of molecular sciences (01-06-2024)“…The bleomycin-induced scleroderma model is a well-established and dependable method for creating a mouse model of SSc (systemic sclerosis). In the field of…”
Get full text
Journal Article -
5
Stevens–Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor
Published in Journal of dermatology (01-11-2019)Get full text
Journal Article -
6
Cytokine‐producing B‐cell balance associates with skin fibrosis in patients with systemic sclerosis
Published in Journal of dermatology (01-10-2022)“…Systemic sclerosis (SSc) is an autoimmune disease characterized by skin and lung fibrosis. Over 90% of patients with SSc are positive for autoantibodies. In…”
Get full text
Journal Article -
7
Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array
Published in Frontiers in immunology (28-08-2023)“…Comprehensive autoantibody evaluation is essential for the management of autoimmune disorders. However, conventional methods suffer from poor sensitivity, low…”
Get full text
Journal Article -
8
Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody
Published in Journal of dermatology (01-09-2022)Get full text
Journal Article -
9
FcγRIIB inhibits inflammation in a murine model of psoriasis
Published in Journal of dermatological science (01-11-2022)“…Psoriasis is a chronic, inflammatory cutaneous disease. FcγRIIB is a low-affinity receptor for the IgG Fc fragment that provides a negative feedback pathway to…”
Get full text
Journal Article -
10
Early improvement of nailfold videocapillaroscopy abnormalities in dermatomyositis patients with anti‐NXP‐2 antibody
Published in Journal of cutaneous immunology and allergy (01-12-2023)“…This study aimed to evaluate long‐term changes in nailfold videocapillaroscopy (NVC) findings in dermatomyositis patients with antinuclear matrix protein 2…”
Get full text
Journal Article -
11
Regulatory B cells and T cell Regulation in Cancer
Published in Journal of molecular biology (08-01-2021)“…[Display omitted] •There are two opposing B cell subsets; effector B cells and regulatory B cells.•Effector B cells have an ability to promote anti-tumor…”
Get full text
Journal Article -
12
Anifrolumab for systemic lupus erythematosus: A clinical study of Japanese patients in Kanazawa University Hospital
Published in Journal of dermatology (01-04-2024)“…We investigated the effectiveness of anifrolumab in treating systemic lupus erythematosus (SLE). We treated seven patients with SLE (age range, 31–68 years;…”
Get full text
Journal Article -
13
Longitudinal changes in nailfold videocapillaroscopy findings differ by myositis-specific autoantibody in idiopathic inflammatory myopathy
Published in Rheumatology (Oxford, England) (01-03-2023)“…To assess the longitudinal changes in nailfold videocapillaroscopy (NVC) in patients expressing myositis-specific autoantibodies [anti-aminoacyl-tRNA…”
Get full text
Journal Article -
14
A case of digital papillary adenocarcinoma with human papillomavirus 42 detected
Published in Journal of dermatology (06-11-2024)Get full text
Journal Article -
15
Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti–topoisomerase I antibody
Published in Journal of dermatology (01-01-2024)“…Interstitial lung disease (ILD) is recognized a prognostic factor and leading cause of death in patients with systemic sclerosis (SSc). The aim of the present…”
Get full text
Journal Article -
16
Clinical features of patients with connective tissue disease with anti–human upstream binding factor antibodies: A single‐center retrospective study
Published in Journal of dermatology (01-05-2024)“…Anti–human upstream‐binding factor (anti‐hUBF) antibodies have been reported predominantly in patients with connective tissue diseases (CTDs); these have also…”
Get full text
Journal Article -
17